Kepler Capital analyst Christian Faitz maintained a Hold rating on Bayer (0P6S – Research Report) on January 21 and set a price target of ...
The "Enterprise Tech Ecosystem Series: Bayer AG 2024" report has been added to ResearchAndMarkets.com's offering. The report provides insights into Bayer AG's tech activities, including its digital ...
The Ministry of Planning and Investment, the Ministry of Foreign Affairs, and FPT Corporation co-hosted a working breakfast in Davos, Switzerland on January 22 to discuss the future and opportunities ...
In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Bayer (0P6S – Research Report), with a price target of ...
The data uncover broad optimism as well as stark regional disparities and cultural obstacles in the West that must be ...
Cola, Bayer and Nestle, showed an interest in investing in Thailand during discussions with Prime Minister Paetongtarn Shinawatra at the World Economic Forum (WEF) in Davos, the government said ...
Then we will focus into the subgroup of Bayer AG to do with pharmaceuticals, Bayer HealthCare. Bayer's beginnings On August 1st 1863, a general partnership called “Friedr Bayer et comp” was ...
Bayer's expanded therapies and strategic collaborations in India aim to drive pharmaceutical growth amidst regulatory challenges and pricing pressures.
Bayer's venerable testosterone replacement product for men with hypogonadism – Nebido – is being sold to Grünenthal as the group continues a revamp of its healthcare business. Grünenthal is ...
Biopharma executives make their predictions for the year ahead, from a bold forecast for the return of the megadeal to a plea ...